Compounds for inhibiting .beta.-amyloid peptide release and/or its synthesis
US6207710A · kind A · utility
6Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 30, 1998 |
| Grant date | Mar 27, 2001 |
| Priority date | — |
| Expiry date | Sep 30, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06191
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit .beta.-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits .beta.-amyloid peptide release and/or its synthesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.